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ABSTRACT 18 
The current study aims to elucidate in greater detail the dermal uptake of nicotine from air or from 19 
nicotine-exposed clothes, which was demonstrated recently in a preliminary study. Six non-smoking 20 
participants were exposed to gaseous nicotine (between 236 and 304 µg/m3) over 5 h while breathing 21 
clean air through a hood. Four of the participants wore only shorts and two wore a set of clean clothes. 22 
One week later, two of the bare-skinned participants were again exposed in the chamber, but they 23 
showered immediately after exposure instead of the following morning. The two participants who 24 
wore clean clothes on week one, were now exposed wearing a set of clothes that had been exposed to 25 
nicotine. All urine was collected for 84 h after exposure and analysed for nicotine and its metabolites 26 
cotinine and 3OH-cotinine. All participants except those wearing fresh clothes excreted substantial 27 
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amounts of biomarkers, comparable to levels expected from inhalation intake. Uptake for one 28 
participant wearing exposed clothes exceeded estimated intake via inhalation by >50%. Excretion 29 
continued during the entire urine collection period, indicating that nicotine accumulates in the skin 30 
and is released over several days. Absorbed nicotine was significantly lower after showering in one 31 
subject, but not the other. Differences in the normalized uptakes and in the excretion patterns were 32 
observed among the participants. The observed cotinine half-lives suggest that non-smokers exposed 33 
to airborne nicotine may receive a substantial fraction through the dermal pathway. Washing skin and 34 
clothes exposed to nicotine may meaningfully decrease exposure. 35 
 36 
Keywords: Exposure Pathway, Biomonitoring, Indoor Environment, Smoking, Skin, Metabolism  37 
  38 
PRACTICAL IMPLICATIONS 39 
Dermal uptake of nicotine from the air in environments with smoking or vaping can continue for a 40 
substantial time after exposure. Wearing clean clothes substantially reduces uptake, but wearing 41 
clothes exposed to nicotine can further increase uptake. Showering shortly after exposure may reduce 42 
uptake.  43 
 44 
1. INTRODUCTION  45 
Exposure to nicotine via dermal contact has been widely studied, with focus on green tobacco leaves 46 
and transdermal patches.1,2 Inhalation is typically the only pathway considered when evaluating 47 
nicotine exposure resulting from passive smoking. Dermal uptake of nicotine from air may however 48 
be an important pathway of exposure among passive smokers, including children. Recent modeling 49 
suggested that dermal uptake of certain organic compounds, including nicotine, directly from air can 50 
be a significant exposure pathway.3,4 Weschler et al.5 experimentally demonstrated for the first time 51 
that dermal uptake of two gas-phase phthalates, diethyl phthalate and di(n-butyl) phthalate, can be 52 
comparable to or higher than intake via inhalation. Morrison et al.6 showed that clean clothing can 53 
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impede, while clothing that has previously absorbed/adsorbed indoor air pollutants can increase 54 
dermal uptake. We have recently demonstrated dermal uptake of airborne nicotine directly from air 55 
or from exposed clothing.7 The air-to-skin-to-blood pathway may also be relevant with regard to 56 
thirdhand smoke, which can be associated not only with indoor surfaces, but also skin and clothes.8 57 
Moreover, evaluating this unexplored route of exposure is all the more important in light of the 58 
increasing adoption of relatively unregulated e-cigarettes.9 E-cigarette use results in elevated levels 59 
of nicotine in air and on surfaces including clothing. Although the exposure conditions may differ 60 
from environments with environmental tobacco smoke (ETS), e-cigarettes are also anticipated to 61 
contribute to public secondhand exposure via the dermal pathway.10,11  62 
 63 
The effect of washing/bathing on dermal uptake directly from air has not been investigated. Hand 64 
washing and showering remove skin lipids and can reduce percutaneous penetration of certain 65 
compounds.12 Washing removed on average 96% of nicotine residue from the hands of tobacco 66 
harvesters.13 In an in vitro study by Zorin et al.14, pure nicotine and nicotine in various concentrations 67 
in water or ethanol was removed by washing three or five minutes after application on human skin. 68 
Permeation through skin continued after removing almost all nicotine from the skin surface, 69 
indicating rapid development of a nicotine reservoir in the skin itself. The cumulative concentration 70 
in the receptor compartment was however greatly reduced when the skin was rinsed after three 71 
minutes compared to five minutes. Whether washing has the potential to reduce dermal uptake of 72 
nicotine after exposure to, for example, second hand smoke is unclear.  73 
 74 
The preliminary study of nicotine absorption from air by Bekö et al.7 was performed on two bare-75 
skinned and one clothed participant. Daily pooled urine samples were collected over 60 hours after a 76 
3-hour exposure in a climate chamber, where nicotine was dosed by continuous smoking of cigarettes 77 
using a smoking machine. The subsequent excretion of nicotine and its metabolites indicated that skin 78 
acts as a reservoir after exposure to airborne nicotine. We concluded that ionization of nicotine on 79 
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the surface of skin or within the stratum corneum does not substantially impede uptake. The study 80 
was, however, limited in extent and detail. Furthermore, the exposures occurred in a setting with very 81 
high particle levels, which confounded interpretation of the results. The current study aims to expand 82 
our knowledge on the dermal uptake of nicotine from air and clothing, by conducting experiments on 83 
a larger number of participants, with more controlled concentrations using pure gas-phase nicotine, a 84 
longer period of exposure and collection of individual urine sample over a longer time. Additionally, 85 
it assesses the effect of showering immediately after exposure on the dermal uptake of nicotine.  86 
 87 
2. METHODS 88 
2.1 Human participants and experimental plan 89 
A total of six male participants were exposed to nicotine to study dermal uptake to bare skin as well 90 
as investigate the impact of showering and clothing. Figure 1 presents a diagram showing the overall 91 
experimental design. One experiment investigated the dermal uptake of nicotine directly from air. 92 
Four healthy males between 50-68 years of age (P1-P4) participated. They were exposed to air 93 
containing nicotine at elevated concentration. The exposure period was five hours. The participants 94 
wore only shorts and breathed clean air through a breathing hood.5 The participants were asked to 95 
shower the night before and again in the morning of the day following exposure. One week later two 96 
of the participants (P3 and P4) were again exposed in the chamber, but they showered immediately 97 
after exposure. In a companion experiment, during the first week two participants (P5 and P6; age 36 98 
and 50 years, respectively) wore a set of clean clothes (underpants, socks, shirt, pants and gloves) 99 
comprised of cotton, polyester and rayon while being exposed to nicotine in a fashion identical to the 100 
bare-skinned participants. During the second week, these participants were exposed wearing identical 101 
shirt, socks and gloves that had been exposed to nicotine at an air concentration of ~500 µg/m3 for 16 102 
days, then ~250 µg/m3 for 11 days. They wore full-length pants and underpants that had been cleaned 103 
and not exposed. All participants were non-smokers and were not exposed to environmental tobacco 104 
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smoke (ETS) or other sources of nicotine during the days prior to the exposure and during the 105 
subsequent urine collection period. 106 
 107 
2.2 Nicotine in chamber air 108 
Nicotine (Table S1) in aqueous solution (1%) was dosed using a step-motor driven syringe in a 55 109 
m3 climate chamber ventilated at an air exchange rate of 0.7 h-1 (the average air temperature during 110 
exposure was 29.8 °C in week 1 and 27.6 °C in week 2). Droplets of the solution were delivered onto 111 
a heated stainless steel plate (35 °C), which evaporated the nicotine into the air. The dosing rate was 112 
1.88 mL/h. To minimize sorption of nicotine on the chamber surfaces, the walls, floor and ceiling of 113 
the chamber were covered with thin polyethylene sheet. Dosing began two days prior to exposure, in 114 
order to establish steady-state nicotine concentration in the chamber air.  115 
 116 
Nicotine in the chamber air was determined by collecting 5 to 6 L of air (100-150 mL/min) on Tenax 117 
TA filled stainless-steel tubes. One sample was taken every hour during exposure and seven duplicate 118 
samples were collected as well. The tubes were analyzed via thermal desorption gas 119 
chromatography/mass spectrometry (TD-GC/MS) according to ISO 16000-6.15 Field blanks from 120 
each day of exposure were also analyzed and the nicotine concentration was in all cases below the 121 
limit of detection (< 1 µg/m³) (see Supporting Information for calibration data; Figures S1 and S2). 122 
Triplicate air samples (5 L of air at a flow 40 mL/min) were collected from one of the breathing hoods 123 
under conditions similar to when the participants were wearing hoods. The average measured nicotine 124 
concentration in breathing hoods was 3.7 µg/m3 (st.dev. = 0.58), less than 2% of the average nicotine 125 
concentration in the chamber air during these experiments. Figure S3 shows an image of the exposure 126 
chamber, nicotine dosing and air sampling.  127 
 128 
2.3 Urine collection and analyses 129 
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One to two urine samples were collected immediately before the participants entered the chamber. 130 
All urine was collected for 84 hours after entering the chamber. For participants P1, P2 and P5 post-131 
exposure urine samples were pooled; one pooled sample contained urine collected within the first 12 132 
hours after the beginning of exposure, the second, third and fourth pooled samples contained urine 133 
collected during the subsequent three 24-hour periods. For participants P3, P4 and P6 all individual 134 
urine samples were collected, weighed and analyzed in order to study in greater detail the impact of 135 
clothing and showering immediately after exposure.  Pooled samples were also prepared for these 136 
participants; they were reconstituted from the individual samples and analyzed together with the 137 
pooled samples of participants P1, P2 and P5 (Figure S4). Urine samples were analyzed for nicotine 138 
and two of its metabolites, cotinine and 3-hydroxycotinine (including their conjugates after enzymatic 139 
hydrolyses) via LC-MS with isotope dilution quantification, as described in Bekö et al.7. The limits 140 
of quantification (LOQ) for nicotine, cotinine and 3-hydroxy-cotinine were 0.10, 0.05 and 0.12 µg/L, 141 
respectively.  142 
 143 
2.4 Data analyses 144 
The mass of nicotine and each metabolite excreted was determined by multiplying the absolute 145 
concentration (µg/L) in the pooled samples by the corresponding urine volume (L). For each pooled 146 
sample, the amounts of nicotine and its metabolites were corrected by the corresponding amounts 147 
measured in the pre-samples collected before entering the chamber, scaled by the ratio of the pooled 148 
sample volume to the pre-sample volume. This allows us to obtain an estimate of dose resulting from 149 
the 5 hours in the chamber. This correction for background exposure is somewhat conservative, as 150 
the background urinary concentrations of nicotine and the two metabolites were somewhat higher in 151 
week 2 compared to week 1 (nicotine 0.18 vs. 0.05 (1/2 LOD) µg/L, cotinine 1.73 vs. 0.28 µg/L and 152 
3OH-cotinine 3.89 vs. 0.51 µg/L, respectively, for participants P3-P6 who were exposed both weeks). 153 
For participants P3, P4 and P6, whose individual samples were analyzed, the excretion mass rate for 154 
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each interval was calculated by dividing the excreted mass per urination by the elapsed time since the 155 
previous urination.  156 
 157 
The half-lives of nicotine and its metabolites were determined from the mass excreted in the last two 158 
pooled samples for each participant. For participants P3, P4 and P6, half-lives were also calculated 159 
from a regression of the last 48 hours of excretion rates (appropriately log-transformed). Half-lives 160 
that were greater than two-times the population mean or less than zero were excluded. 161 
 162 
The total uptake of nicotine was calculated from the excreted amounts of nicotine and its metabolites 163 
using the following molecular weights (g/mol): nicotine: 162, cotinine: 176, 3-hydroxy-cotinine: 192. 164 
We estimated the amount of nicotine absorbed by assuming that 90% of nicotine and its metabolites 165 
are excreted via urine and that the three metabolites and their conjugates constitute 85% of 166 
metabolites excreted in urine.16 We then subtracted the amount of nicotine inhaled from hood air (IU), 167 
calculated by the following equation: 168 
IU = BR*Cair*f*t = 9 µg   (1) 169 
where BR is the breathing rate (0.7 m3/h), Cair is the average air concentration in the hood (3.7 µg/m3), 170 
f is the fraction of inhaled nicotine that is absorbed (0.7; see Bekö et al.7 for details) and t is the 171 
exposure time (5h).  172 
 173 
Finally, total uptakes of nicotine were normalized first by the chamber air concentrations of nicotine 174 
and then by the participant’s exposed body surface area (BSA, based on the method of DuBois and 175 
DuBois17). Ninety percent of BSA was used for bare-skinned participants and for participants wearing 176 
fresh clothes. For participants wearing exposed clothes, we assumed that their normalized exposure 177 
from air during the 5 hours in the chamber will be the same as when they were wearing fresh clothes. 178 
This fraction of their uptake was normalized by 90% of BSA. The remaining fraction of the uptake 179 
was attributable to the exposed shirt, gloves and socks and was normalized by 52% of BSA.18 The 180 
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final normalized uptake of participants wearing exposed clothes was thus determined using the 181 
following equation: 182 
𝑈𝑈𝑈𝑈𝑈𝑈𝑈𝑈𝑈𝑈𝑈𝑈 = 𝑀𝑀2𝐶𝐶2−𝑀𝑀1𝐶𝐶1
52% 𝐵𝐵𝐵𝐵𝐵𝐵 + 𝑀𝑀1𝐶𝐶190%𝐵𝐵𝐵𝐵𝐵𝐵    (2) 183 
where M1 and M2 are the background and hood concentration corrected absorbed dose while wearing 184 
fresh clothes and absorbed clothes, respectively (µg) and C1 and C2 are the corresponding nicotine 185 
air concentrations during the two exposure periods (µg/m3).  186 
 187 
The research protocol was approved by the Capital Region of Denmark Committee for Research 188 
Ethics (case no. H-16018670).  189 
 190 
3. RESULTS  191 
The physiological parameters of the six participants and the nicotine air concentrations are 192 
summarized in Table 1. The average nicotine concentration in chamber air was between 236 µg/m3 193 
and 240 µg/m3 in the first week of the experiment and between 281 µg/m3 and 304 µg/m3 in the 194 
second week (Figure S5).  195 
 196 
3.1 Excreted amounts of nicotine and metabolites 197 
Following exposure, the concentrations of nicotine and nicotine metabolites in the urine of the bare-198 
skinned participants (P1-P4) quickly increased considerably above the levels measured before they 199 
entered the chamber. They excreted a significant amount of nicotine and nicotine metabolites (Table 200 
1 and Figures 2 and S6). Substantial differences were observed in the net excretion patterns among 201 
participants. Participant P1 excreted large amounts of nicotine and cotinine, while participant P2 202 
excreted much more 3OH-cotinine than nicotine or cotinine, reflecting faster metabolism by 203 
participant P2. Participant P3 excreted similar amounts of the three compounds the first exposure 204 
week. In week two, when he showered immediately after exposure, he excreted substantially smaller 205 
amounts of nicotine and cotinine, but not 3OH-cotinine. Participant P4, however, excreted twice as 206 
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much nicotine, slightly more cotinine and comparable amount of 3OH-cotinine in week 2 compared 207 
with week 1, when showering did not occur immediately after exposure. Differences were also seen 208 
between the two clothed participants (Figures 3 and S7). Participant P5 excreted similar amounts of 209 
cotinine and 3OH-cotinine and less nicotine, while participant P6 excreted substantially more 3OH-210 
cotinine than nicotine and cotinine, both when wearing clean clothes and exposed clothes.  211 
 212 
The excreted amounts of nicotine and the two metabolites obtained from pooled samples were 213 
compared with those from individual samples for participants P3, P4 and P6 (Figures 3 and S6, and 214 
Table S2). The identical trends and similar absolute values obtained by the two methods indicate that 215 
the results from reconstituted pooled samples reliably represent the observed exposure and can be 216 
analyzed together with the data from participants P1, P2 and P5, who collected pooled urine only.  217 
 218 
Net excretions of the three compounds continued to increase throughout the 84 h post-exposure period 219 
for all participants. Nicotine absorption associated with the chamber exposure was not completely 220 
captured even after 3.5 days of urine collection. This is supported by the excretion rates shown in 221 
Figure 4, especially in the case of the nicotine metabolites that exhibit delayed excretion and longer 222 
elimination half-lives compared to nicotine. Excretion rates peaked 1-1.5 days after exposure began 223 
(somewhat later for metabolites) and then decayed. Half-lives of the three compounds are shown in 224 
Table 2 and Figure S8. The average half-lives for nicotine, cotinine and 3OH-cotinine were 28h 225 
(SD14), 35h (SD 15), and 34h (SD 19), respectively. For participants P3, P4 and P6, half-lives of 226 
cotinine based on total mass excreted on consecutive days (24h pools) were generally consistent with 227 
those based on a regression of excretion rates from individual samples. 228 
 229 
3.2 Nicotine uptake 230 
The back-calculated amount of dermally absorbed nicotine (dose) varied among the participants 231 
(Table 1). The average dose was 650 µg for the bare-skinned participants during week 1 (range 460-232 
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820 µg). After normalization by body surface area and chamber air concentration, the average dose 233 
was 1.53 µg/m2/(µg/m3) (range 1.22-1.8; Figure 5). For participants who showered immediately after 234 
exposure, normalized absorbed nicotine was lower than without showering, by 52% for participant 235 
P3 and 6% for participant P4. For the two participants wearing clean clothes, the amount of absorbed 236 
nicotine was 25 µg and 85 µg (0.06 and 0.18 µg/m2/(µg/m3)), substantially lower than for the bare-237 
skinned participants. It increased to 470 µg and 1144 µg (1.6 and 3.1 µg/m2/(µg/m3)) while wearing 238 
clothes (not pants) previously exposed to nicotine. The clothing was responsible for ~95% of this 239 
uptake (Figure 5).  240 
 241 
4. DISCUSSION 242 
4.1 Urine concentrations and absorbed dose 243 
Peak concentrations in the 12- or 24-hour pooled urine samples of the bare-skinned participants 244 
(between 10 and 85 ng/ml, data not shown) were similar to those of the two bare-skinned participants 245 
in Bekö et al.7 and comparable to levels measured among non-smokers in hospitality environments 246 
before the smoking ban. Peak concentration in the individual urine samples were slightly higher 247 
(nicotine: 102 ng/ml (P3), 89 ng/ml (P4); cotinine: 71 ng/ml (P3), 38 ng/ml (P4); 3OH-cotinine: 123 248 
ng/ml (P3), 68 ng/ml (P4)), approaching levels measured in light smokers.19 The total absorbed dose 249 
of nicotine for the bare-skinned participants in week 1 (average 650 µg) was similar to the minimum 250 
uptake estimated for bare-skinned participants based on 60h excretions in Bekö et al.7 (570 µg). Given 251 
the long elimination half-lives and the observation that metabolites are still being excreted at the end 252 
of urine collection, these doses underestimate the total nicotine absorbed.  253 
 254 
The airborne nicotine concentration was higher in the earlier study (420 µg/m3), where the source of 255 
nicotine was environmental tobacco smoke. However, exposure lasted longer in the current study (5 256 
h vs. 3 h). Moreover, the absence of particles in the current study is expected to increase the fraction 257 
of total nicotine in the gas-phase.20 Nicotine air concentrations were higher than concentrations 258 
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reported for most environments where smoking occurs. They were comparable to the levels reported 259 
for smoking sections of UK and German pubs and to mean levels measured in German 260 
discotheques.21,22 The slightly higher average concentration in the second week reflects a lower rate 261 
of nicotine removal by participants; only two participants were seated in the chamber compared to 262 
three exposed participants in the first week.  263 
 264 
Nicotine and metabolite concentrations measured in pooled samples for the participants wearing clean 265 
clothes were low (15 ng/ml). Clean clothes are expected to be protective for compounds like nicotine 266 
that meaningfully sorb to clothing fibers, reducing the rate of transport to the skin.23 When the 267 
participants wore a set of exposed clothes, the concentrations were comparable or higher than for the 268 
bare-skinned participants (peak nicotine: 29 ng/ml (P5), 55 ng/ml (P6); peak cotinine: 46 ng/ml (P5), 269 
43 ng/ml (P6); peak 3OH-cotinine: 48 ng/ml (P5), 148 ng/ml (P6)). These concentrations are higher 270 
than observed in Bekö et al.7, which is probably due to a longer pre-exposure of the clothes, a longer 271 
wearing time in the chamber and a larger body surface area covered with exposed clothes. The total 272 
uptakes of participants P5 and P6 with exposed clothes covering only part of the body (~50%) were 273 
similar or higher than uptakes of the bare-skinned (~90% exposed) participants, indicating a higher 274 
uptake rate when wearing exposed clothes.6 Compared to the earlier nicotine study, the clothing in 275 
the current experiment had been exposed to elevated concentrations of nicotine for a longer time, and 276 
had likely come much closer to equilibrium with nicotine in the chamber air.  277 
 278 
4.2 Accumulation in skin and cotinine half-lives 279 
Excretion of nicotine and its metabolites (above generally observable background levels) continued 280 
throughout the entire period of urine collection. This observation supports earlier conclusions that 281 
skin acts as a reservoir for chemicals that accumulated during exposure and delivers them into the 282 
blood after exposure.7,24,25 Comparison of background nicotine and metabolite concentrations 283 
measured in the pre-exposure samples collected in weeks 1 and 2 further supports this hypothesis. 284 
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The average concentrations of nicotine, cotinine and 3OH-cotinine in the pre-exposure samples in 285 
week 1 were <LOD, 0.28 and 0.51 µg/L, respectively. During week 2 they were 0.18, 1.73 and 3.89 286 
µg/l, respectively. None of the individual background levels in week 1 was higher than the 287 
corresponding value from week 2. The slightly higher pre-exposure levels in week 2 may be due to 288 
somewhat higher background exposures during the days prior to entering the chambers in week 2 (for 289 
which we have no indication). More likely, the higher starting concentrations reflect metabolism and 290 
excretion of residual nicotine present in the body one week after the first exposure. Additionally, the 291 
ratio of week 2 to week 1 background urine concentrations were higher for the bare-skinned 292 
participants (range 1-18) than for the clothed participants (1-5), possibly due to the much lower 293 
exposure of the latter participants during week 1.  294 
 295 
The observed cotinine half-lives are similar to, but somewhat larger than those of non-smokers 296 
exposed to ETS (Table 2 and Figure S8). Smokers take in most of their nicotine by inhalation and 297 
have cotinine half-lives of ~16 h.26 Exposure to nicotine in airborne ETS results in a much longer 298 
half-life (27h).26 The average dermal-only half-life, observed in the current study is 35 h based on 299 
pooled samples and 33h based on individual samples (P3, P4 and P6). These values suggest that 300 
exposure of nonsmokers to nicotine in airborne ETS is from a combination of inhalation and dermal 301 
absorption, since the resulting half-life is between that for mainstream smoking and dermal 302 
absorption. However, given the small number of participants, coupled with the variability of the 303 
measured half-lives, these results should be interpreted with caution. 304 
 305 
4.3 Comparison with inhalation uptake 306 
We can estimate what the inhalation uptake during the 5h chamber exposure would be, had the 307 
subjects not been wearing a breathing hood. Using a breathing rate of 0.7 m3/h 18, the measured 308 
nicotine air concentrations, and a value of 0.7 for the fraction of inhaled nicotine absorbed,7 the 309 
inhalation uptake is between 580 and 750 µg, depending on the nicotine concentration in the air on 310 
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the day of exposure. These doses are comparable to the observed dermal uptakes of the bare-skinned 311 
participants in week 1 (average 650 µg, Table 1). However, the 5 h exposure time is too short for 312 
dermal uptake from the gas-phase to reach steady state.27 Longer exposure time would result in 313 
dermal uptake rates closer to steady-state values and larger than uptake via inhalation. Wearing 314 
previously exposed clothes can further increase dermal absorption. The uptake of nicotine for 315 
participant P6 was 50% higher than the corresponding inhalation uptake without a hood would have 316 
been even though only about half of the participant’s skin was covered by nicotine-exposed clothes.  317 
 318 
4.4 Differences in normalized uptake 319 
Differences were observed in the normalized uptakes between the four bare-skinned participants in 320 
week 1 as well as between the two participants wearing fresh or exposed clothes. Contrary to the 321 
results of our earlier studies indicating increasing dermal uptake with age for lipophilic 322 
compounds,5,24 nicotine uptake during week 1 was the lowest for the oldest participant. However, in 323 
our previous study the older of the two participants (identical to P4 in the current study) had a higher 324 
normalized uptake compared with his 32 years younger counterpart.7 The older of the two clothed 325 
participants in the current study had higher normalized uptake both with fresh and exposed clothes. 326 
Age therefore cannot explain the differences in uptake between the participants. The differences could 327 
have been caused to a certain extent by differences in skin type (thickness, hydration, pH, buffering 328 
capacity), sweating, desquamation, lipid content and other skin conditions such as that related to 329 
filaggrin gene loss-of-function mutation.28,29 The type of clothes worn after exiting the exposure 330 
chamber may have had an effect as well. The substantial difference between the uptakes of the two 331 
participants wearing exposed clothes may have been additionally influenced by the cloth-skin gap 332 
(i.e., the clothes fitting more tightly on the participant with larger BSA (2.24 m2 vs. 1.93 m2)).24,23 333 
Other parameters, such as geometry and permeability of the fabric, laundering and exposure of the 334 
clothes to nicotine prior to wearing were identical for the two participants. Studies with more 335 
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participants are warranted to better elucidate the effect of age and clothing on dermal uptake of 336 
nicotine. 337 
 338 
Both participants P3 and P4 had a lower normalized uptake in week 2 when they showered 339 
immediately after exposure in the chamber. After exiting the exposure chamber in week 1, the 340 
participants donned clothing, which is anticipated to reduce absorption due to transfer of nicotine 341 
from skin lipids to clothing.27,23 Showering in week 2 likely removed more effectively a fraction of 342 
the nicotine in skin surface lipids that had not yet penetrated into the epidermis and the dermis. The 343 
reduction of uptake after showering was much smaller in case of the older participant. It is plausible 344 
that nicotine was absorbed more quickly from the surface of the skin, as older skin tends to be drier 345 
(less ionization) and has a thinner epidermis.30,31 Additionally, we did not control for the duration of 346 
showering, water temperature and soap applied. These factors influence skin dryness, skin pH and 347 
consequently nicotine ionization and removal.  348 
 349 
4.5 Factors affecting nicotine clearance 350 
The differences among the excretion patterns of the six individuals were substantial. For example, 351 
participant P2 metabolized nicotine fast and excreted more than 80% of the total (nicotine + 352 
metabolites expressed as nicotine equivalents) in the form of metabolites (~50% as 3OH-cotinine), 353 
while participant P1 excreted 55% as metabolites (~15% as 3OH-cotinine). Given the small number 354 
of participants, we cannot reach clear conclusions regarding differences in nicotine metabolism 355 
following dermal uptake. Nonetheless, some discussion of factors that influence nicotine clearance 356 
seems appropriate. 357 
 358 
The availability and activity of the enzymes responsible for nicotine and cotinine metabolism may 359 
partially explain the observed differences.32 Variations in urine flow and urine pH, may also influence 360 
the results. It is noteworthy that there were different excretion patterns for the same individual – in 361 
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week 1 participant P4 rapidly metabolized nicotine, excreting only 22% of the total excreted amount 362 
as nicotine; in week 2, his metabolism of nicotine was slower (36% excreted as nicotine); in the 363 
previous study, the same individual (participant 1 in Bekö et al.7) metabolized nicotine even more 364 
slowly (44% excreted as nicotine). Nicotine is primarily metabolized in the liver, indicating that it 365 
depends on liver blood flow and therefore on physiological factors such as diet and exercise.16 366 
Although animal studies suggest potential metabolism to a small extent in other organs, comparable 367 
human studies are lacking. We cannot evaluate the contribution from metabolism in the skin, as is 368 
known to occur for other compounds (e.g., DEHP).33  369 
 370 
Diurnal rhythms have been shown to affect nicotine clearance. We observed peak nicotine excretion 371 
rates to occur at or just before midnight (Figure S9). This is most apparent in the results of participant 372 
P4, who urinated more frequently than the other participants. Hepatic blood flow falls and nicotine 373 
clearance decreases during sleep. Gries et al.34 modeled nicotine clearance in an experiment of 48-374 
hour constant intravenous nicotine bitartrate administration to 11 subjects for 48 hours. In contrast to 375 
the results shown in Figure S9, the earlier investigators found that nicotine clearance peaked around 376 
11 AM and was lowest between 6 PM and 3 AM. The difference may reflect exposure via dermal 377 
absorption in the present study versus an intravenous pathway in the cited study. Gries et al.34 also 378 
found that eating a meal increased clearance on average by 42% at peak, which occurred one hour 379 
after beginning the meal. The effect of the meal lasted nearly three hours. Taken together, circadian 380 
rhythms and changes in food ingestion and urine flow may explain the diurnal excretion rates of 381 
nicotine and the fluctuating ratios of individual excreted amounts of the three compounds (Figure 382 
S10).  383 
 384 
For the reasons discussed above, it is unclear whether age plays a role in the observed differences in 385 
metabolism. Participants P1 and P2, with different metabolic patterns, were close in age. The older 386 
clothed participant (P6) metabolized cotinine very fast and excreted nearly 60% of the total excreted 387 
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amount of nicotine equivalent as 3OH-cotinine both weeks of the experiment, compared to 35-50% 388 
in case of the younger participant P5. However, the oldest participant P4 metabolized nicotine 389 
relatively quickly in week 1, although he metabolized it substantially slower in our earlier study. 390 
Gourlay and Benowitz35 did not find differences in steady-state nicotine plasma or estimated plasma 391 
clearance in three age groups with nicotine patches. However, decreased clearance of nicotine has 392 
been reported for subjects above 65 years compared to adults between 22 and 43 years,36 perhaps 393 
reflecting reduced liver blood flow.37 Cotinine clearance is much slower and more dependent on 394 
enzyme activity, which does not change with age.38 Indeed, the range for 3OH-cotinine/cotinine ratios 395 
among the participants was substantially smaller than that of the cotinine/nicotine or 3OH-396 
cotinine/nicotine ratios (Figure S10).  397 
 398 
5. CONCLUSIONS 399 
Following our pilot study,7 this more extensive study supports our earlier finding that nicotine can be 400 
dermally absorbed directly from air at rates comparable to or higher than via inhalation. Wearing 401 
clean clothes significantly decreases short-term uptake, while wearing exposed clothes increases 402 
uptake. Similar to contact exposure, nicotine absorbed dermally from air or clothing accumulates in 403 
the skin and is released over a period of several days, perhaps up to a week. The cotinine half-life 404 
observed in the present study, compared to cotinine’s reported half-life following ETS exposure, 405 
suggests that a fraction of the exposure of non-smokers to ETS may occur through dermal absorption. 406 
Uptake and metabolism of nicotine after dermal exposure via air varies substantially between 407 
individuals. In addition to skin condition, genetic variations in metabolic enzymes, age and diet may 408 
be responsible for the variation. Washing the skin after exposure may decrease the amount of 409 
absorbed nicotine. The efficacy of skin washing likely depends on a number of factors and warrants 410 
further investigation. Frequent laundering of clothes that are regularly exposed to tobacco smoke or 411 
nicotine from vaping is anticipated to reduce nicotine uptake through skin. 412 
 413 
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Tables and Figures 520 
 521 
Table 1. Nicotine air concentrations during exposure, net amount of nicotine and the two metabolites excreted 522 
over 84 hours after entering the chamber (corrected for background concentrations before entering the 523 
chamber), absorbed nicotine dose (corrected for background concentration and nicotine concentration in the 524 
breathing hood), and normalized uptake determined from the pooled urine samples.  525 
Participant Age BSA (m2) 
Date of 
exposure 
Aver. 
nicotine 
conc. in 
air ± 
SD 
(µg/m3) 
Excreted 
Nicotine 
(µg)* 
Excreted 
Cotinine 
(µg)* 
Excreted 
3OH-
Cotinine 
(µg)* 
Estimated 
Dose 
(µg)* 
Uptake 
normalized by 
adjusted 
BSA** & air 
conc. 
(µg/m2/µg/m3) 
P1 50 2.16 27.9.2016 236±22 279 275 124 823 1.80 
P2 51 2.07 28.9.2016 240±23 82.9 183 270 616 1.38 
P3 55 1.92 27.9.2016 236±22 183 193 225 711 1.74 P3-shower 5.10.2016 281±19 90.7 91.4 172 409 0.84 
P4 68 1.73 28.9.2016 240±23 78.1 129 189 457 1.22 P4-shower 4.10.2016 304±26 152 148 160 543 1.15 
P5-fresh clothes 36 1.93 28.9.2016 240±23 2.4 11.2 15.4 25 0.06 P5-exposed clothes 5.10.2016 281±19 106 149 146 470 1.62 
P6-fresh clothes 50 2.24 27.9.2016 236±22 14.7 18.0 48.1 85 0.18 P6-exposed clothes 4.10.2016 304±26 192 215 584 1144 3.10 
* background corrected (see section 2.4) 526 
** 90% BSA was used for bare-skinned participants and for participants wearing fresh clothes. For participants wearing 527 
exposed clothes, equation (2) was applied to normalize by adjusted BSA. 528 
 529 
 530 
Table 2. Half-lives (h) of nicotine, cotinine and 3OH-cotinine based on last two consecutive 24-h excretion 531 
rates (pooled samples) and successive-urination excretion rates (individual samples; P3, P4 and P6 only). 532 
Participant Nicotine Cotinine 3OH-cotinine 
P1 34 * * 
P2 54 25 26 
P3 9 (12) 19 (23) 43 (*) 
P3-shower 37 (25) 27 (40) 17 (22) 
P4 38 (33) 33 (39) 17 (22) 
P4-shower 24 (23) 43 (34) 38 (40) 
P5-fresh clothes 21 42 55 
P5-exposed clothes 25 51 72 
P6-fresh clothes * (*) 17 (20) 17 (19) 
P6-exposed clothes 11 (12) 62 (42) 22 (23) 
Average; SD 28; 14 (21; 9) 35; 15 (33; 9) 34; 19 (25; 8) 
* negative or unrealistically large 533 
 534 
 535 
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 536 
Figure 1. Experimental plan 537 
 538 
 539 
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  540 
 541 
542 
Figure 2. Net amount of excreted nicotine and the two metabolites for the four bare-skinned participants (P1-543 
P4). Participants P3 and P4 showered immediately after exposure on the second week (right), but not the first 544 
(left). 545 
 546 
  547 
Figure 3. Net amount of excreted nicotine and the two metabolites for one of the clothed participants, P6. Data 548 
from both the individual and pooled urine samples are shown for comparison. Note the different scales on the 549 
vertical axis. (See the Supporting Information for this comparison for the other participants.) 550 
 551 
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 552 
Figure 4. Urinary excretion rates of nicotine and its two metabolites for participants P3 (bare-skinned), P4 553 
(bare-skinned) and P6 (clothed).  554 
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 555 
Figure 5. Dermally absorbed nicotine normalized by chamber air concentration and adjusted body surface 556 
area. The grey horizontal bar indicates the range of inhalation intake for participants P1-P4, normalized by air 557 
concentration and corresponding BSA (90% of total BSA).  558 
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